STAT3 ChIPseq of PC-9 and KHM-3S with and without tarceva

27/05/2015
22 samples
DAC: EGAC00001000199
Technology: Illumina HiSeq 2000

Access Policy1 Study Files

Metadata

Request Access

Department of Discovery Oncology -- Genentech

Permission from DAC members are required before accessing the data.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID	Study Title	Study Type
	Two lung cancer cell lines with EGFR mutations, PC-9 and KHM-3S, were either treated with Tarceva for 24 hours or left untreated. The gene expression profiles were examined by RNAseq, and the genome wide binding profiles of total STAT3 and pSTAT3 were characterized by ChIPseq.	Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID	File Type	Size
EGAF00000530566	fastq.gz	518.1 MB
EGAF00000530567	fastq.gz	1.1 GB
EGAF00000530568	fastq.gz	1.2 GB
EGAF00000530569	fastq.gz	1.2 GB
EGAF00000530570	fastq.gz	625.1 MB
EGAF00000530571	fastq.gz	1.4 GB
EGAF00000530572	fastq.gz	443.5 MB
EGAF00000530574	fastq.gz	522.0 MB
EGAF00000530575	fastq.gz	1.4 GB
EGAF00000530577	fastq.gz	1.2 GB
EGAF00000530578	fastq.gz	1.9 GB
EGAF00000530579	fastq.gz	634.8 MB
EGAF00000530581	fastq.gz	1.0 GB
EGAF00000530582	fastq.gz	1.0 GB
EGAF00000530583	fastq.gz	624.1 MB
EGAF00000530584	fastq.gz	1.5 GB
EGAF00000530585	fastq.gz	1.6 GB
17 Files (18.0 GB)